| 000 | 01769 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517201626.0 | ||
| 264 | 0 | _c20190205 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1469-3178 | ||
| 024 | 7 |
_a10.15252/embr.201642139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, Shar-Yin N | |
| 245 | 0 | 0 |
_aMitochondrial tyrosyl-DNA phosphodiesterase 2 and its TDP2 _h[electronic resource] |
| 260 |
_bEMBO reports _c03 2018 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 |
_aAlternative Splicing _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDNA-Binding Proteins |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
| 650 | 0 | 4 | _aGene Knockout Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhosphoric Diester Hydrolases |
| 650 | 0 | 4 |
_aProtein Isoforms _xgenetics |
| 650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
| 700 | 1 | _aDalla Rosa, Ilaria | |
| 700 | 1 | _aMichaels, Stephanie A | |
| 700 | 1 | _aTulumello, David V | |
| 700 | 1 | _aAgama, Keli | |
| 700 | 1 | _aKhiati, Salim | |
| 700 | 1 | _aJean, Sae Rin | |
| 700 | 1 | _aBaechler, Simone A | |
| 700 | 1 | _aFactor, Valentina M | |
| 700 | 1 | _aVarma, Sudhir | |
| 700 | 1 | _aMurai, Junko | |
| 700 | 1 | _aMiller Jenkins, Lisa M | |
| 700 | 1 | _aKelley, Shana O | |
| 700 | 1 | _aPommier, Yves | |
| 773 | 0 |
_tEMBO reports _gvol. 19 _gno. 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.15252/embr.201642139 _zAvailable from publisher's website |
| 999 |
_c28081488 _d28081488 |
||